DUBLIN--(BUSINESS WIRE)--The "Recombinant Protein Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type (Growth Hormones, Interferons, Vaccines, Immunostimulating Agents), By Source, ...

The market analysis reveals a robust growth trajectory, propelled by factors such as the rising prevalence of chronic diseases, increasing investments in biotechnology research, and growing demand for ...

DUBLIN--(BUSINESS WIRE)--The "Protein Therapeutics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Protein Therapeutics was estimated at ...

The engineering and production of antibodies are vital in drug discovery, offering effective and precise therapeutics and diagnostic/prognostic materials for numerous diseases. Antibodies are proteins ...

The Global Protein Therapeutics Market is estimated to be valued at USD 345.82 Bn in 2025 and is expected to reach USD 558.95 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.1% from ...

Today’s clinicians use recombinant therapeutic proteins, such as monoclonal antibodies, to treat many diseases, from autoimmune disorders to cancer and beyond. Nonetheless, sequence variants (SVs), ...

Recent successes of recombinant proteins as therapeutics have greatly increased the number of companies developing such therapies. However, protein therapeutics and vaccines are frequently difficult ...

ProSpecBio, an evolving biotech company dedicated to providing highly purified proteins to the global research community, today announced the launch of its latest product: CHO cell–derived recombinant ...

Dr. Jin Wang, Michael E. DeBakey, M.D., Endowed Professor in Pharmacology and director of the new Center for NextGen Therapeutics at Baylor College of Medicine explains what this center has to offer ...

Akari is targeting an Investigational New Drug (IND) application submission to the U.S. Food and Drug Administration in the first half of 2024 Composition of matter patent application filed on ...